The Cannigma

MAY 5, 2021

While the research doesn’t provide any clear answers, here is what we do know. Furthermore, a comprehensive review published in January 2021 asserted that “it was estimated that 80% of the patients that were infected with SARS-CoV-2 developed one or more long-term symptoms.” What is long COVID? episodes per month.

Chronic Pain 144

Chronic Pain Research and Development Patients Treatment 144

Puff Puff Post

JANUARY 24, 2019

“There were times when I was told you couldn’t even use ‘cannabis’ and ‘research’ in the same sentence,” he recalled. which is conducting millions of dollars worth of research on the use of cannabis to treat conditions including anxiety, insomnia and pain. The federal government is investing in marijuana research too.

Research and Development 111

Research and Development Legalization Marijuana Recreational 111

Project CBD

SEPTEMBER 12, 2023

When scientists blocked the CB1 cannabinoid receptor, ketamine did not prevent pain. The same group of researchers also found that ketamine caused anandamide (one of two major endocannabinoids) to be released in certain brain areas. Eighty-five percent of chronic pain patients also suffer from depression,” says Dr. Weiner.

Chronic Pain 233

Chronic Pain Treatment Cannabinoids Research and Development 233

Cannabis Law Report

AUGUST 10, 2021

Enters into the Chronic Pain Market with Psychedelics. binding letter of intent signed on July 12th 2021 to purchase certain assets of Cannvalate Pty Ltd. (“Shanti”), and all its assets focused on psychedelic MDMA-based drug development. The global chronic pain treatment market is predicted to progress at a CAGR of 6.5%

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Puff Puff Post

JULY 8, 2019

. – July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes. She is the Founder & CEO of Canna Research Group. About Canna Research Group.

Chronic Pain 109

Chronic Pain Research and Development Clinical Trials THC 109

Puff Puff Post

JULY 8, 2019

. – July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes. She is the Founder & CEO of Canna Research Group. About Canna Research Group.

Chronic Pain 108

Chronic Pain Research and Development Clinical Trials THC 108

Cannabis Law Report

JULY 21, 2021

The treatment is designed to target nociplastic pain originating in the central nervous system through the neuroplasticity benefits of psilocybin. Research Investigator, University of Michigan Department of Anesthesiology. Director of the Chronic Pain & Fatigue Research Center. investors@tryptherapeutics.com.

Clinical Trials 105

Clinical Trials Chronic Pain Research and Development Treatment 105

MMJ Recs

AUGUST 20, 2021

The use of cannabis in scientific research in the US has been at a standstill for the last five decades. The limit on where scientists could access cannabis for research was limited to just one facility at the University of Mississippi. What does federally funded cannabis research mean for medical marijuana development?

Access 52

Access Research and Development Marijuana Chronic Pain 52

United Patients Group

FEBRUARY 8, 2023

It’s no wonder that doctors are looking for new ways to treat patients with chronic pain without resorting to these highly addictive substances. Opioids are also prescribed to treat pain and other medical conditions such as coughs, diarrhea and muscle spasms. Cannabinoids may have potential in treating chronic pain.

Chronic Pain 105

Chronic Pain Cannabinoids Research and Development Patients 105

MGC Pharma

FEBRUARY 15, 2018

A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. This means that while the future looks brighter for chronic pain sufferers, the same can’t be said for recreational usage.

Access 100

Access Medicine Chronic Pain Research and Development 100

MMJ Recs

SEPTEMBER 10, 2021

When the COVID-19 pandemic began, medical researchers were scrambling to find the best way to treat the viral infection. With that research came various treatment options, some of which were shown to be viable, with others being deemed unsuitable. One such treatment option that researchers have looked into is medical cannabis.

Treatment 98

Treatment Chronic Pain Research and Development Sleep 98

MMJ Recs

DECEMBER 28, 2023

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option. Medical marijuana, however, has emerged as a potential alternative.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

PrestoDoctor

SEPTEMBER 26, 2023

Research suggests that cannabis can affect various aspects of mental health , including mood, cognition, and behavior. It’s important to note that not everyone who uses cannabis will develop mental health issues. Research suggests that there is indeed a link between cannabis use and mental health issues.

Research and Development 105

Research and Development Chronic Pain Sleep Conditions 105

United Patients Group

JULY 7, 2023

While there is still much research to be done on the potential benefits and risks of medical cannabis, there is a growing body of evidence that suggests it can be a valuable tool for managing chronic pain, anxiety and depression, nausea and vomiting, seizures, inflammation, sleep, and other health conditions.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

Sensi Seeds

DECEMBER 10, 2018

At the same time, research on medical cannabis over the past two decades has not ceased to increase and provide evidence of the plant’s medical value. As a result, medical and scientific research has been highly constrained for many decades. Exponential Increase in Cannabis Research: Trends.

Medicine 81

Medicine Research and Development Data Policy 81

MMJ Recs

NOVEMBER 17, 2023

It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Licensing fees, taxes, and other revenue sources associated with MMJ operations generate income that can be reinvested in public services, healthcare initiatives, and community development.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

FloridaMarijuana.net

OCTOBER 18, 2018

A 2006 edition of Current Pharmacology published an article titled: “Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes”. If this system consistently has a shortage in the endocannabinoid system, disease or illness could develop.

Cannabinoids 169

Cannabinoids THC Chronic Pain Patients 169

The Herb Collective

MARCH 1, 2024

This versatile plant, which has been both vilified and celebrated throughout history, is finally getting the recognition it deserves in various sectors, including medicine, wellness, and sustainable development. Cannabidiol (CBD), one of the many compounds found in cannabis, has been at the forefront of this revolution.

Research and Development 105

Research and Development Chronic Pain Medicine History 105

The Cannigma

MARCH 2, 2021

This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

LifeCannMD

JANUARY 2, 2025

#image_title Medical Marijuana vs. Traditional Pharmaceuticals: A Patient’s Guide to Understanding Your Options When discussing Medical Marijuana for managing chronic pain , Dr. Fernando Fandio-Sende has fielded many questions. Miami patients often ask how it compares to traditional medications they have been taking for years.

Pharmaceutical 98

Pharmaceutical Chronic Pain Marijuana Blood Pressure 98

CannaMD

NOVEMBER 4, 2020

Cannabis has been used for centuries to manage chronic pain from all sources and, as a recent study highlights, its positive effects extend to migraines. Other Research Findings. The present study relied on Migraine Buddy , a leading mobile application that tracks migraine symptoms. Of the 40 million sufferers in the U.S.,

Patients 105

Patients Chronic Pain Marijuana Research and Development 105

PrestoDoctor

SEPTEMBER 6, 2023

Codeine works by binding to opioid receptors in the brain, blocking pain signals and providing a sense of relief. Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Cannabis Law Report

JUNE 28, 2021

Cannabis products are fast becoming available that could deliver significant improvements to the lives of thousands of patients suffering from conditions ranging from chronic pain to post traumatic stress disorder. Kanabo is an established leader in medical cannabis research and innovation.

Research and Development 105

Research and Development Chronic Pain Medicine Policy 105

MMJ Recs

FEBRUARY 21, 2024

This article delves into the impact of medical marijuana on various aspects of women’s well-being, addressing key areas such as reproductive health, menstrual health, mental health, hormonal balance, pain management, wellness, and specific health conditions.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 111

Consumption Patients Research and Development Data 111

MGC Pharma

FEBRUARY 22, 2018

While at home in Australia, the Medical Cannabis industry is still working hard to gather more evidence-based research to substantiate treatment assertions, relevant studies are already occurring overseas. It’s heartening to see the release of more and more evidence-based global research surrounding Medical Cannabis-based treatment.

Research and Development 100

Research and Development Pharmaceutical Chronic Pain Treatment 100

Cannabis Law Report

JULY 5, 2021

A Suffolk MP has joined the board of a medical cannabis research company, describing the firm’s work as a “crucially important endeavour” Dr Dan Poulter, MP for Central Suffolk and North Ipswich, has been appointed a non-executive director of Kanabo Group.

Research and Development 81

Research and Development Chronic Pain Medicine Vaping 81

Canna Law Blog

FEBRUARY 19, 2020

Federally, legislation has been proposed to allow research into psychedelic drugs, alongside calls for decriminalization. Research companies, along with FDA, are seemingly “all in” on psilocybin’s potential in battling treatment-resistant depression. At the state level, ballot measures are out for signature in California and Oregon.

Decriminalization 131

Decriminalization Therapy Research and Development Pharmaceutical 131

Veriheal

FEBRUARY 7, 2022

Now, a study from researchers at the University of Michigan has concluded that it may also be a favorite among creative geniuses of today—specifically, the software developers that make all the magic happen behind the scenes. For the study, 803 programmers were recruited from GitHub + University, including 450 full-time developers.

Research and Development 98

Research and Development Programs Chronic Pain Hash 98

Veriheal

MAY 3, 2022

A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research. Understanding of CUD.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. Understanding how to discern reliable sources, interpret research methodologies, and apply key findings to real-world scenarios can be daunting.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

APRIL 26, 2022

Growth of the worldwide legal cannabis market is unlikely to slow down anytime soon, according to the findings of a new report published by analysts at Research and Markets. Region : A long list of locations were analyzed by researchers, including the Americas, Asia-Pacific, Europe, the Middle East, and Africa. billion by 2026.

Supply Chain 98

Supply Chain Legalization Research and Development Chronic Pain 98

United Patients Group

MARCH 15, 2023

Cannabis is a natural treatment for pain and other symptoms of withdrawal. Cannabis has been shown to be effective in treating chronic pain; it’s also been shown to reduce the amount of opioids needed by patients who take them (and thus reduce side effects). Cannabis can help to manage the side effects of drugs.

Pharmaceutical 98

Pharmaceutical Patients Chronic Pain Sleep 98

MMJ Recs

AUGUST 14, 2024

Over time, medical marijuana for managing neuropathic pain has gained attention as an encouraging alternative, thanks to the positive outcomes many patients have experienced. This article explores various aspects of using medical marijuana to alleviate neuropathic pain, offering tips and insights based on the latest medical research.

Nerve Pain 96

Nerve Pain Marijuana Strains Chronic Pain 96

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. Chronic pain conditions such as arthritis and neuropathy often find relief through ECS modulation, reducing inflammation and pain perception.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105